Axulta, Kapseln

7680654020017 CH-65402 Kapseln

Associated product:

Axulta, Kapseln

No image available

Article details

Package size
7
Selling units
7
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
linaclotidum
0.29 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
hypromellosum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
leucinum
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
propylenglycolum
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
lacca
- Substance HNIDK
ammoniae solutio concentrata
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
65402
Drug name
Axulta, Kapseln
Galenic form
KAHA
ATC Code
A06AX04
Authorization status
Z
Dispensing category
B
First authorization
24/03/2015
Authorization expiration date
31/12/9999
IT Number
04.08.11
Domain
Human medicine
Field of application
Symptomatische Behandlung von moderatem bis schwerem Reizkolon-Syndrom mit Obstipation bei Erwachsenen

Package details

Description (FR)
AXULTA caps 0.29 mg 7 pce
Description (DE)
AXULTA Kaps 0.29 mg 7 Stk
Narcotic (BTM)
No

Other package sizes (4)

None
10 KAP
GTIN: None
Not in V1
None
28 KAP
GTIN: None
Not in V1
None
60 KAP
GTIN: None
Not in V1
None
90 KAP
GTIN: None
Not in V1
Buy us a coffee Explore the data